P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclibMark C. de Gooijer, Olaf van Tellingen, Levi C.M. Buil et al.|Investigational New Drugs|2015Cited by 85
Author response for "Acquired and intrinsic resistance to vemurafenib in BRAF<SUP>V600E</SUP>-driven melanoma brain metastases"Ping Zhang, Mark C. de Gooijer, Laura E. Kuil et al.|Unknown|2023Cited by 0